Acknowledgements
Cancer
ONCOLOGY, CANCER
We wish to thank the patients who participated in the ICORG 10-05 clinical trial and the healthy volunteers who provided blood samples. The clinical trial was sponsored by the All-Ireland Clinical Oncology Research Group (ICORG), now known as Cancer Trials Ireland – CTRIAL-IE, which received funding from GlaxoSmith-Kline, the owners of lapatinib at the initiation of the study. Lapatinib is now a commodity of Novartis.